SE512093C2 - Sports drink comprising a non cariogenic liquid and separately packaged carbohydrates coated with non cariogenic carrier material for controlled release - Google Patents
Sports drink comprising a non cariogenic liquid and separately packaged carbohydrates coated with non cariogenic carrier material for controlled releaseInfo
- Publication number
- SE512093C2 SE512093C2 SE9801803A SE9801803A SE512093C2 SE 512093 C2 SE512093 C2 SE 512093C2 SE 9801803 A SE9801803 A SE 9801803A SE 9801803 A SE9801803 A SE 9801803A SE 512093 C2 SE512093 C2 SE 512093C2
- Authority
- SE
- Sweden
- Prior art keywords
- preparation
- cariogenic
- composition
- container
- carbohydrates
- Prior art date
Links
- 230000001013 cariogenic effect Effects 0.000 title claims abstract description 16
- 239000007788 liquid Substances 0.000 title claims abstract description 14
- 150000001720 carbohydrates Chemical class 0.000 title claims abstract description 9
- 235000014633 carbohydrates Nutrition 0.000 title claims abstract description 9
- 238000013270 controlled release Methods 0.000 title claims abstract 5
- 235000011496 sports drink Nutrition 0.000 title description 4
- 239000012876 carrier material Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 claims abstract description 23
- 239000008280 blood Substances 0.000 claims abstract description 16
- 210000004369 blood Anatomy 0.000 claims abstract description 16
- 208000002925 dental caries Diseases 0.000 claims abstract description 13
- 230000037081 physical activity Effects 0.000 claims abstract description 9
- 230000000694 effects Effects 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 6
- 230000003340 mental effect Effects 0.000 claims abstract description 5
- 239000000969 carrier Substances 0.000 claims abstract description 3
- 238000002360 preparation method Methods 0.000 claims description 23
- 235000003599 food sweetener Nutrition 0.000 claims description 3
- 239000003765 sweetening agent Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 239000008298 dragée Substances 0.000 claims 1
- 239000007888 film coating Substances 0.000 claims 1
- 238000009501 film coating Methods 0.000 claims 1
- 235000005985 organic acids Nutrition 0.000 claims 1
- 238000009472 formulation Methods 0.000 abstract 4
- 235000021074 carbohydrate intake Nutrition 0.000 abstract 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 230000009747 swallowing Effects 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000003914 insulin secretion Effects 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000036642 wellbeing Effects 0.000 description 2
- 206010049119 Emotional distress Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010044038 Tooth erosion Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/32—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents for packaging two or more different materials which must be maintained separate prior to use in admixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mechanical Engineering (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
...WW mi.. . m. fiJ. ... WW mi ... m. fi J.
Hahn »um ü| 512 093 10 15 20 25 30 35 2 skall vika. Olika typer av fysisk aktivitet medför olika totalbehov av energi och olika tidpunkt när energi be- höver tillföras. Till exempel behöver en maratonlöpare eller cyklist en tämligen låg tillförsel av energi under en kontinuerlig lång tid, medan en sprinter behöver sin energi under kort tid. Maratonlöparen kan dra nytta av en långsam och definierad sockertillförsel. En sprinter har ett betydligt mer intensivt sockerbehov under kortare tid.Hahn »um ü | 512 093 10 15 20 25 30 35 2 shall fold. Different types of physical activity entail different total energy needs and different times when energy is need to be added. For example, need a marathon runner or cyclist a rather low supply of energy during a continuous long time, while a sprinter needs his energy for a short time. The marathon runner can benefit from one slow and defined sugar supply. A sprinter has a significantly more intense sugar requirement during shorter time.
En långsam höjning av blodsockerhalten innebär att insulininsöndringen blir långsam. När sockret är för- brukat minskar risken för en alltför låg blodsockerhalt orsakad av en rekyleffekt genom vilken för mycket insulin insöndrats. Detta kan ske vid en plötslig hög blodsocker- koncentration, d.v.s. vid intag av alltför stora mängder socker. En för låg blodsockerhalt innebär fysisk trötthet och psykisk olust, varigenom prestationsförmågan minskas.A slow rise in blood sugar levels means that insulin secretion becomes slow. When the sugar is used reduces the risk of too low a blood sugar level caused by a recoil effect by which too much insulin secreted. This can happen with a sudden high blood sugar concentration, i.e. if ingested in excessive amounts sugar. Too low a blood sugar level means physical fatigue and mental distress, thereby reducing performance.
Därför bör socker tillföras kontinuerligt under lång tid vid exempelvis maratonlöpning eller motsvarande för upp- nående av en optimal prestation.Therefore, sugar should be added continuously for a long time for example in marathon running or equivalent for reaching an optimal performance.
Vid många typer av idrottsutövning är det ett van- ligt konsumtionsmönster att sportdryck intages med en mycket hög frekvens. Detta kan exempelvis innebära att man dricker 10-20 gånger under en innebandymatch, vilket medför en dramatiskt ökad risk för tandkaries och tand- erosioner, speciellt om mönstret upprepas ofta.In many types of sports, it is a common consumption pattern that sports drinks are consumed with a very high frequency. This may, for example, mean that you drink 10-20 times during a floorball match, which entails a dramatically increased risk of dental caries and erosions, especially if the pattern is repeated frequently.
Kaloriinnehållet i dessa drycker överstiger dessutom nästan alltid det faktiska behovet.The caloric content of these drinks also exceeds almost always the actual need.
Många motionerar för att minska sin vikt, men en konventionell energiinnehållande sportdryck motverkar oftast detta syfte. Eftersom dryckerna har en friskhets- och hälsoprofil, är konsumenten sällan medveten om detta faktum. Även vid ansträngande psykisk aktivitet, som vid inten- siva studier under längre tid (tentaläsning), kan till- försel av socker kortvarigt öka välbefinnandet och minska trötthet. 'šååï-Ûfi-ZÛ 'lf/I i ii) (å: '~.I?z7-."å“-.'F»':ÉLÉ\?-f:ï.?~“~ f” 'b \) 'v Cl) CI \) 1 a w 10 15 20 25 30 35 512 093 Problemen med sportdrycker kan sammanfattas enligt följande: 1. Dryckerna innehåller socker och konsumeras genom ett stort antal upprepade doseringar, varvid risken för karies och tanderosioner ökar högst väsentligt för per- soner som tränar eller motionerar dagligen eller flera gånger i veckan. 2. Eftersom dryckerna har fått stämpeln ”hälsosamma” är konsumenterna inte medvetna om den tandskadliga effekt som föreligger. 3. Eftersom dryckerna innehåller mer energi än vad som krävs, motverkar de viktminskning. 4. Energiinnehållet i dryckerna är inte avpassat för alla typer av motion. 5. Vätske- och energibehovet följer inte varandra under ett motionspass. 6. När man t ex joggar eller spinger under mer än 30 minuter är man ofta så andfådd att det är svårt att dricka utan att negativa effekter från mag/-tarmkanalen uppstår, varigenom välbefinnandet minskar. 7. Konsumentupplysning på förpackningen avseende dryckens energiinnehåll i förhållande till det aktuella energibehovet saknas.Many people exercise to reduce their weight, but one conventional energy-containing sports drink counteracts usually this purpose. Since the drinks have a freshness and health profile, the consumer is rarely aware of this fact. Even with strenuous mental activity, as with intense long-term studies (dental reading), may be supply of sugar briefly increase well-being and decrease fatigue. 'šååï-Ûfi-ZÛ' lf / I i ii) (å: '~ .I? z7 -. "å“ -.' F »': ÉLÉ \? - f: ï.? ~“ ~ f ”' b \) 'v Cl) CI \) 1 a w 10 15 20 25 30 35 512 093 The problems with sports drinks can be summarized according to following: 1. The drinks contain sugar and are consumed through a large number of repeated doses, whereby the risk of caries and tooth erosions increase most significantly for per- sons who train or exercise daily or more times a week. 2. Since the drinks have been stamped "healthy" Consumers are not aware of the tooth-damaging effect available. Because the drinks contain more energy than what required, they counteract weight loss. 4. The energy content of the drinks is not adapted for all types of exercise. 5. The need for fluids and energy do not follow each other during an exercise session. 6. When, for example, jogging or spinning for more than 30 minutes you are often so out of breath that it is difficult to drink without adverse effects from the gastrointestinal tract occurs, thereby reducing well-being. 7. Consumer information on the packaging regarding the energy content of the beverage in relation to the current the energy need is missing.
Sammanfattning av uppfinningen Ändamålet med föreliggande uppfinning är att lösa ovanstående problem. Detta ändamål uppnås genom att be- redningen av det inledningsvis angivna slaget har de sär- drag som anges i efterföljande patentkrav l med före- dragna utföringsformer i efterföljande patentkrav 2-8. Ändamålet uppnås även genom en behållare med särdrag i enlighet med efterföljande patentkrav 9-10, användning av nämnda beredning eller behållare i enlighet med särdrag i enlighet med efterföljande patentkrav ll-12 samt genom det inledningsvis angivna förfarandet med de särdag som anges i efterföljande patentkrav 13 med föredragna ut- föringsformer i efterföljande patentkrav 14-15. 512 093 10 15 20 25 30 35 Nämnda ändamål uppnås genom att vätska och en komposition innehållande socker (eller andra energiinnehållande kol- hydrater) tillförs i en oral beredning utan att sockret kommer i kontakt med tänderna, vilket åstadkommes genom att sockret är belagt med en farmaceutiskt godtagbar icke-kariogen bärare, såsom gelatin eller motsvarande, varvid kompositionen sväljs hel. Medelst nämnda för- farande, och tillhörande beredning, motverkas således uppkomst av karies vid intag av energi i form av socker.Summary of the invention The object of the present invention is to solve the above problems. This object is achieved by the preparation of the kind initially indicated, the special features set out in the following claim 1 with drawn embodiments in the appended claims 2-8. The purpose is also achieved through a container with features in according to the following claims 9-10, use of said preparation or container in accordance with the features of according to the following claims 11-12 and by the procedure initially set out in the special day stated in the following claim 13 with preferred embodiments embodiments in the appended claims 14-15. 512 093 10 15 20 25 30 35 Said object is achieved by liquid and a composition containing sugar (or other energy-containing hydrates) are added in an oral preparation without the sugar comes into contact with the teeth, which is accomplished by that the sugar is coated with a pharmaceutically acceptable non-cariogenic carriers, such as gelatin or the like, whereby the composition is swallowed whole. By means of the said process, and associated preparation, are thus counteracted onset of caries when consuming energy in the form of sugar.
Kompositionen och vätskan kallas tillsammans för dosför- packning eller förpackning.The composition and the liquid are collectively referred to as dosage packing or packaging.
Vätskan kan vara vatten med tillsatser valda ur en grupp bestående av icke-kariogena salter, icke-kariogena sötningsmedel och organiska eller oorganiska syror. Som exempel kan nämnas mineralvatten med tillsats av bikar- bonat, som är sötad med icke-kariogena sötningsmedel.The liquid may be water with additives selected from one group consisting of non-cariogenic salts, non-cariogenic sweeteners and organic or inorganic acids. As examples include mineral water with the addition of bonat, which is sweetened with non-cariogenic sweeteners.
Vätskan används alltså dels för sväljning av komposi- tionen och dels för tillfredställelse av vätskebehovet.The liquid is thus used partly for swallowing composites. tion and partly for the satisfaction of the liquid demand.
Som exempel på energiinnehållande kolhydrater kan nämnas sackaros, glukos, fruktos, maltos, laktos och stärkelsehydrolysat.As an example of energy-containing carbohydrates can mentioned sucrose, glucose, fructose, maltose, lactose and starch hydrolyzate.
Beredningen enligt uppfinningen kan exempelvis före- ligga som en förpackning av en typ som illustreras i fig 1 och fig 2. Vätskebehållaren och det belagda sockret (kompositionen) är förvarade i var sin behållare, som är avtagbart fästade till varandra.The preparation according to the invention may, for example, lie as a package of a type illustrated in FIG 1 and Fig. 2. The liquid container and the coated sugar (the composition) are stored in separate containers, which are removably attached to each other.
Energiinnehållet i kompositionen är definierat och utmärkt i enheter som kalorier och/eller kilojoule el dyl för att konsumenten skall veta hur mycket energi som tillförs genom varje dos. Märkningen kan finnas direkt på dosförpackningen och/eller framgå genom färgkodning. För att en användare skall veta hur mycket energi som behövs, och vid vilken tidpunkt den behövs, är energiinnehållet översatt till hur mycket som åtgår för olika typer av kroppsövningar, såsom joggning, cykling mm., och framgår av en tabell på förpackningen. För olika typer av kropps- '~ F12 'EES PPI _ 10 15 20 25 30 35 m w: 5 övningar kommer energibehovet efter olika lång tid. Detta framgår av tabeller på förpackningen (fig 2). Även för- packningen är företrädesvis siffer- och/eller färgkodad.The energy content of the composition is defined and excellent in units such as calories and / or kilojoules etc. for the consumer to know how much energy administered through each dose. The label can be found directly on the dose package and / or appear by color coding. For that a user should know how much energy is needed, and at what time it is needed is the energy content translated to how much is needed for different types of physical exercises, such as jogging, cycling, etc., and appears of a table on the package. For different types of body '~ F12' EES PPI _ 10 15 20 25 30 35 m w: 5 Exercises will boost energy needs after varying lengths of time. This can be seen from tables on the packaging (fig. 2). Even for- the packing is preferably number and / or color coded.
Innehållet i kompositionen kan vara granulerat och/eller sammanpressat. De granulerade kornen kan i sig vara dragerade eller blandade med drageringssubstansen för àstadkommande av långsammare upplösning. Även entero- kapslar kan användas.The contents of the composition may be granulated and / or compressed. The granulated grains can in themselves be coated or mixed with the coating substance to achieve slower resolution. Also enteric capsules can be used.
Kompositionen intas en viss tidpunkt innan energin behövs i blodet. Som exempel på tidpunkt kan nämnas ca 5- 60 minuter, företrädevis ca 30 minuter. Själva upptaget av sockret kan ske via sk fördröjd frisättning (”slow release”) direkt i tarm. Effekten av detta är en långsam höjning av blodsockerhalten. En långsam höjning av blod- sockerhalten innebär att insulininsöndringen blir lång- sam. När sockret är förbrukat minskar risken för en allt- för låg blodsockerhalt genom rekyleffekt p g a att allt- för mycket insulin insöndrats.The composition is taken at a certain time before the energy needed in the blood. As an example of time can be mentioned about 5- 60 minutes, preferably about 30 minutes. Very busy of the sugar can take place via so-called delayed release (“slow release ”) directly in the intestine. The effect of this is a slow one increase in blood sugar. A slow increase in blood sugar content means that insulin secretion is prolonged sam. When the sugar is consumed, the risk of an all- too low blood sugar content due to recoil effect due to too much insulin secreted.
Kompositionen kan även intas för momentan verkan, och denna åstadkommes lämpligtvis genom upptag i mag- säcken, vilket i sin tur åstadkommes genom att komposi- tionen utrustats med en beläggning som upplöses direkt i magsäcken. Detta kan behövas vid plötslig och/eller akut trötthet.The composition can also be taken for instantaneous action, and this is conveniently accomplished by uptake into the stomach. the sack, which in turn is achieved by equipped with a coating that dissolves directly in stomach. This may be needed in the event of a sudden and / or emergency fatigue.
Vid långvarig psykisk aktivitet, såsom tentamens- läsning, medför behovet att höja blodsockerhalten ofta ett frekvent intag av godis, kaffe med socker mm. Detta innebär ökad risk för karies, enligt tidigare resonemang, och uppfinningen kan med fördel användas även i samband med sådan psykisk aktivitet.During prolonged mental activity, such as examination reading, often causes the need to raise blood sugar levels a frequent intake of sweets, coffee with sugar etc. This entails an increased risk of caries, according to previous reasoning, and the invention can advantageously also be used in connection with such mental activity.
Många läkemedel är dragerade eller på annat sätt förpackade för att bli tillgängliga för absorption först en viss tid efter nedsväljandet eller under en förutbe- stämd tid. Detta är normalt en följd av att de förstörs vid kontakt med magsaft eller att de orsakar någon slags irritation och/eller smakar illa. Vid sådan dragering kommer innehållet inte i kontakt med tänderna, och denna 512 093 6 teknik är välkänd. Det torde dock stå klart att denna teknik ej tidigare utnyttjats för lösning av de olika problem som beskrivits ovan. ~~ r- -\ .w “__ Jífu., . mir...Many drugs are coated or otherwise packaged to be available for absorption first a certain time after swallowing or during a pre-swallowing timed time. This is normally a consequence of their destruction in contact with gastric juice or that they cause any kind irritation and / or taste bad. In such coating the contents do not come into contact with the teeth, and this 512 093 6 technology is well known. However, it should be clear that this technology not previously used for solving the various problems described above. ~~ r- - \ .w “__ Jífu.,. mir ...
Claims (15)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9801803A SE512093C2 (en) | 1998-05-22 | 1998-05-22 | Sports drink comprising a non cariogenic liquid and separately packaged carbohydrates coated with non cariogenic carrier material for controlled release |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9801803A SE512093C2 (en) | 1998-05-22 | 1998-05-22 | Sports drink comprising a non cariogenic liquid and separately packaged carbohydrates coated with non cariogenic carrier material for controlled release |
Publications (3)
Publication Number | Publication Date |
---|---|
SE9801803D0 SE9801803D0 (en) | 1998-05-22 |
SE9801803L SE9801803L (en) | 1999-11-23 |
SE512093C2 true SE512093C2 (en) | 2000-01-24 |
Family
ID=20411408
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9801803A SE512093C2 (en) | 1998-05-22 | 1998-05-22 | Sports drink comprising a non cariogenic liquid and separately packaged carbohydrates coated with non cariogenic carrier material for controlled release |
Country Status (1)
Country | Link |
---|---|
SE (1) | SE512093C2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019185742A1 (en) | 2018-03-27 | 2019-10-03 | Laminaria Group Ab | Nutritional supplements |
US11503852B2 (en) | 2016-04-29 | 2022-11-22 | Laminaria Group Ab | Nutritional supplements |
US11510430B2 (en) | 2016-04-29 | 2022-11-29 | Laminaria Group Ab | Nutritional supplements |
-
1998
- 1998-05-22 SE SE9801803A patent/SE512093C2/en not_active IP Right Cessation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11503852B2 (en) | 2016-04-29 | 2022-11-22 | Laminaria Group Ab | Nutritional supplements |
US11510430B2 (en) | 2016-04-29 | 2022-11-29 | Laminaria Group Ab | Nutritional supplements |
WO2019185742A1 (en) | 2018-03-27 | 2019-10-03 | Laminaria Group Ab | Nutritional supplements |
Also Published As
Publication number | Publication date |
---|---|
SE9801803L (en) | 1999-11-23 |
SE9801803D0 (en) | 1998-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Taitz | Infantile overnutrition among artificially fed infants in the Sheffield region | |
Milosevic | Sports drinks hazard to teeth. | |
Jeukendrup et al. | Carbohydrate-electrolyte feedings improve 1 h time trial cycling performance | |
Van Nieuwenhoven et al. | The effect of two sports drinks and water on GI complaints and performance during an 18-km run | |
WO2004089110A2 (en) | Hydration beverage and method of delivering nutrients | |
CA1065672A (en) | Dietary supplement, and dietary methods employing said supplement for the treatment of obesity | |
CN102415523A (en) | Composition containing compound functional food factor | |
US6013290A (en) | Assemblage of nutrient beverages and regimen for enhancing convenience, instruction, and compliance with exercise supplementation | |
Rosenthal | Nutritional concerns in the older surgical patient | |
WO2004047765A2 (en) | Compositions, methods, and kits for weight loss and inhibiting the loss of lean body mass | |
SE512093C2 (en) | Sports drink comprising a non cariogenic liquid and separately packaged carbohydrates coated with non cariogenic carrier material for controlled release | |
US9993448B2 (en) | Bolus dose of hydroxycitric acid with glycerol | |
Bernstein et al. | The small intestine and the control of meal patterns of the rat | |
EP2505201A1 (en) | Trmp5 inhibitors support body weight reduction without reducing food intake | |
Sclafani | Feeding inhibition and death produced by glucose ingestion in the rat | |
Gaskin et al. | Nutritional status, growth and development in children undergoing intensive treatment for cystic fibrosis | |
JP2005027524A (en) | Oral amino acid composition | |
McIntyre et al. | Nocturnal nasogastric tube feeding at home | |
Khavari | Some parameters of sucrose and saline ingestion | |
Singh et al. | Dietary requirements for ultra-endurance exercise | |
Hillemeier et al. | Effect of bethanechol and metoclopramide on upper gastrointestinal motility in the kitten | |
ES2285855T3 (en) | FOOD SUPPLEMENTS THAT INCLUDE LIPOIC ACID AND CREATININE, METHODS FOR USE. | |
US20080050455A1 (en) | Equine gastric ulcer therapy compositions and equine ulcer management method | |
US20080152696A1 (en) | Use of Leptin for the Prevention of Excess Body Weight and Composition Containing Leptin | |
US8512682B2 (en) | Food product to prevent tooth decay |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |